Qlaris Bio
Signal active
Organization
Contact Information
Overview
Qlaris Bio is a clinical stage biotechnology company that develops innovative first-in-class therapies for patients suffering from serious and debilitating ophthalmic diseases. Qlaris Bio is exploring novel mechanisms of action to address episcleral venous pressure (EVP), the largest component of intraocular pressure (IOP), to reduce the risk of blindness in glaucoma, including Primary Open Angle Glaucoma and Normal tension Glaucoma.
About
Industries
Biotechnology, Health Care, Medical
Founded
2019
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Qlaris Bio headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $1.2B in funding across 24 round(s). With a team of 1-10 employees, Qlaris Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Qlaris Bio, raised $24.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
5
Lead Investors
0
Total Funding Amount
$49.0M
Details
2
Qlaris Bio has raised a total of $49.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | 25.0M | ||
| 2024 | Early Stage Venture | 24.0M |
Investors
Qlaris Bio is funded by 14 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| New Leaf Venture Partners | - | FUNDING ROUND - New Leaf Venture Partners | 24.0M |
| Correlation Ventures | - | FUNDING ROUND - Correlation Ventures | 24.0M |
| Qlaris Bio | - | FUNDING ROUND - Qlaris Bio | 24.0M |
| Abrdn | - | FUNDING ROUND - Abrdn | 24.0M |
Recent Activity
There is no recent news or activity for this profile.